CPHI vs PFE · rev $4.1M vs P/E 20, rev $62.58B
China Pharma Holdings Inc (CPHI) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CPHI currently screens at market cap $29.0M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CPHI and PFE stock pages for the full models.
Not investment advice.